Literature DB >> 6672105

Myelopoiesis of human bone marrow cells in a micro-agar culture system: comparison of two sources of colony stimulating activity (CSA).

G Konwalinka, C Peschel, D Geissler, J Boyd, B Tomaschek, R Odavic, H Braunsteiner.   

Abstract

Human bone marrow cells were grown in a micro-agar culture system in the presence of human placenta (HPCM) and giant cell tumor conditioned media (GCT). The effects of HPCM and GCT conditioned media on linearity, growth dynamics, and morphological composition of colonies were studied after 7 and 14 days of incubation. Under the described conditions the dose-response curves for HPCM and GCT were different: on day 7 maximal stimulation was obtained with 2.5% HPCM and 20% GCT; on day 14 a maximal response was reached with 1.25% HPCM and 5% GCT. Both stimuli produced maximal growth after 7 days of incubation, followed by a rapid decrease in the number of formed colonies up to day 14. The morphological study of aggregates showed that after 7 days of incubation 80% pure granulocyte and 20% mixed granulocyte-macrophage colonies were found in the presence of both stimuli. However, on day 14 the incidence of granulocyte-macrophage colonies increased to 60%, whereas the percentage of pure granulocyte colonies decreased to 20%. The frequency of eosinophil colonies was relatively low (median 15%) with both stimuli. The described system can be applied successfully for studies of myelopoiesis in vitro. Both sources of colony stimulating activitites (CSA) employed had no significant difference in their ability to stimulate myelopoiesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6672105     DOI: 10.1002/stem.5530010507

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  3 in total

1.  Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia.

Authors:  W Knapp; O Majdic; H Stockinger; P Bettelheim; K Liszka; U Köller; C Peschel
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

2.  Immunological characterization of canine hematopoietic progenitor cells.

Authors:  J Hahn; H J Kolb; M Schumm; K Beisser; J Ellwart; P Rieber; J Maldacker; N Schwella; L K Lösslein; E Holler
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

3.  Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia.

Authors:  W E Aulitzky; C Peschel; D Desprès; J Aman; P Trautman; H Tilg; G Rudolf; H Hüttmann; J Obermeier; M Herold
Journal:  Ann Hematol       Date:  1993-11       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.